Find Out: The Best Way to Tap into Rising Demand of Lithium in India
Here is the latest financial fact sheet of TRANSGENE BI. For more details, see the TRANSGENE BI quarterly results and TRANSGENE BI share price.
1 Day | % | -5.0 |
No. of shares | m | 75.77 |
1 Week | % | 20.3 |
1 Month | % | 110.7 |
1 Year | % | 208.6 |
52 week H/L | Rs | 9.5/2.3 |
No. of Mths Year Ending |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
TRANSGENE BI EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 3 | 6 | 5 | 7 | 6 | |
Low | Rs | 2 | 2 | 2 | 3 | 3 | |
Sales per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Earnings per share (Unadj.) | Rs | -0.8 | -1.2 | -1.4 | -1.4 | -1.4 | |
Diluted earnings per share | Rs | -0.8 | -1.2 | -1.4 | -1.4 | -1.4 | |
Cash flow per share (Unadj.) | Rs | 0.5 | 0.1 | -0.1 | -0.1 | -0.1 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 6.9 | 5.8 | 4.3 | 2.9 | 2.3 | |
Adj. book value per share | Rs | 6.9 | 5.8 | 4.3 | 2.9 | 2.3 | |
Shares outstanding (eoy) | m | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | |
Price / Sales ratio | x | 168.8 | 419.5 | 7,815.1 | 216.8 | 390.9 | |
Avg P/E ratio | x | -3.1 | -3.4 | -2.5 | -3.5 | -3.3 | |
P/CF ratio (eoy) | x | 5.8 | 27.1 | -25.7 | -69.8 | -70.9 | |
Price / Book Value ratio | x | 0.4 | 0.7 | 0.8 | 1.7 | 2.0 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 200 | 299 | 274 | 367 | 339 | |
Total wages/salary | Rs m | 2 | 2 | 3 | 2 | 3 |
TRANSGENE BI INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1 | 1 | 0 | 2 | 1 | |
Other income | Rs m | 74 | 20 | 2 | 3 | 2 | |
Total revenues | Rs m | 75 | 21 | 2 | 4 | 3 | |
Gross profit | Rs m | -21 | -7 | -9 | -5 | -5 | |
Depreciation | Rs m | 99 | 99 | 99 | 99 | 99 | |
Interest | Rs m | 10 | 3 | 4 | 3 | 2 | |
Profit before tax | Rs m | -57 | -88 | -110 | -104 | -104 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 8 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | -64 | -88 | -110 | -104 | -104 | |
Gross profit margin | % | -1,783.0 | -948.0 | -21,584.0 | -307.3 | -530.4 | |
Effective tax rate | % | -13.9 | 0 | 0 | 0 | 0 | |
Net profit margin | % | -5,456.4 | -12,384.1 | -274,056.0 | -6,138.0 | -11,957.3 |
TRANSGENE BI BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 8 | 6 | 7 | 7 | 7 | |
Current liabilities | Rs m | 138 | 125 | 137 | 142 | 92 | |
Net working cap to sales | % | -11,047.3 | -16,751.2 | -325,549.5 | -7,955.9 | -9,779.2 | |
Current ratio | x | 0.1 | 0.1 | 0 | 0 | 0.1 | |
Inventory Days | Days | 411,157 | 683,382 | 12,136,276 | 285,645 | 558,564 | |
Debtors Days | Days | 26,125,339 | 43,419,577 | 770,697,500 | 18,134,059 | 35,434,368 | |
Net fixed assets | Rs m | 1,858 | 1,759 | 1,661 | 1,562 | 1,464 | |
Share capital | Rs m | 758 | 758 | 758 | 758 | 758 | |
"Free" reserves | Rs m | -233 | -321 | -431 | -535 | -584 | |
Net worth | Rs m | 524 | 436 | 327 | 222 | 174 | |
Long term debt | Rs m | 38 | 41 | 43 | 45 | 48 | |
Total assets | Rs m | 1,866 | 1,765 | 1,668 | 1,569 | 1,471 | |
Interest coverage | x | -4.5 | -32.4 | -27.8 | -37.5 | -44.2 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | |
Sales to assets ratio | x | 0 | 0 | 0 | 0 | 0 | |
Return on assets | % | -2.9 | -4.8 | -6.3 | -6.5 | -6.9 | |
Return on equity | % | -12.3 | -20.2 | -33.6 | -46.9 | -59.9 | |
Return on capital | % | -8.2 | -17.9 | -28.6 | -38.0 | -45.9 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 1 | 1 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 1 | 1 | 0 | 0 | 0 |
TRANSGENE BI CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -6 | -17 | 1 | 0 | 1 | |
From Investments | Rs m | 30 | 17 | 0 | -0 | -1 | |
From Financial Activity | Rs m | -24 | 0 | -2 | 0 | 0 | |
Net Cashflow | Rs m | 1 | -0 | -1 | -0 | -0 |
Share Holding
Shareholding as on Sep 2023
|
Company Information
|
CHM: K Koteswara Rao | COMP SEC: Ankita Jain | YEAR OF INC: 1990 | BSE CODE: 526139 | FV (Rs): 10 | DIV YIELD (%): - |
More Hospital & Healthcare Services Company Fact Sheets: ADANI PORTS & SEZ HDFC GOLDIAM INTERNATIONAL PDS MULTI. REDINGTON
Compare TRANSGENE BI With: ADANI PORTS & SEZ HDFC GOLDIAM INTERNATIONAL PDS MULTI. REDINGTON
On Tuesday, Indian share markets consolidated in a narrow range and closed firmly in green.